These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31491730)

  • 21. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
    Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
    PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
    Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
    Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of different glucose-lowering therapies on cancer incidence in type 2 diabetes: An observational population-based study.
    Vicentini M; Ballotari P; Giorgi Rossi P; Venturelli F; Sacchettini C; Greci M; Mangone L; Pezzarossi A; Manicardi V
    Diabetes Res Clin Pract; 2018 Sep; 143():398-408. PubMed ID: 29807100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced risk of prostate cancer in a cohort of Lithuanian diabetes mellitus patients.
    Kincius M; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
    Aging Male; 2020 Dec; 23(5):1333-1338. PubMed ID: 32410514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.
    Lee CK; Jung M; Jung I; Heo SJ; Jeong YH; An JY; Kim HI; Cheong JH; Hyung WJ; Noh SH; Kim HS; Rha SY; Chung HC
    Ann Surg; 2016 Jan; 263(1):96-102. PubMed ID: 25575260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer.
    Spillane S; Bennett K; Sharp L; Barron TI
    Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1364-73. PubMed ID: 23753040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin use in cancer survivors with diabetes reduces all-cause mortality, based on the Korean National Health Insurance Service between 2002 and 2015.
    Kim J; Bae YJ; Lee JW; Kim YS; Kim Y; You HS; Kim HS; Choi EA; Han YE; Kang HT
    Medicine (Baltimore); 2021 Mar; 100(11):e25045. PubMed ID: 33725979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin usage and the risk of colorectal cancer: a national cohort study.
    Lee JW; Choi EA; Kim YS; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kim J; Kang HT
    Int J Colorectal Dis; 2021 Feb; 36(2):303-310. PubMed ID: 32968891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.
    Spratt DE; Beadle BM; Zumsteg ZS; Rivera A; Skinner HD; Osborne JR; Garden AS; Lee NY
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):523-531. PubMed ID: 26867881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between Metformin Use and Survival in Nonmetastatic Rectal Cancer Treated with a Curative Resection: A Nationwide Population Study.
    Ki YJ; Kim HJ; Kim MS; Park CM; Ko MJ; Seo YS; Moon SM; Choi JA
    Cancer Res Treat; 2017 Jan; 49(1):29-36. PubMed ID: 27384155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study.
    Kim YI; Kim SY; Cho SJ; Park JH; Choi IJ; Lee YJ; Lee EK; Kook MC; Kim CG; Ryu KW; Kim YW
    Aliment Pharmacol Ther; 2014 Apr; 39(8):854-63. PubMed ID: 24612291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of metformin on colorectal carcinoma in type 2 diabetes mellitus patients: a Markov model analysis].
    Su T; Liao B; Dong Y; Peng Z; Zhou Q; Li B; Peng S; Zhang N
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):689-693. PubMed ID: 28643317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study.
    Chu PT; Chuang TJ; Huang SH; Wu TH; Huang WC; Wang JH
    J Int Med Res; 2023 Apr; 51(4):3000605231168033. PubMed ID: 37077173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival.
    Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32824907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
    Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin use and prostate cancer risk.
    Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
    Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and cancer-specific survival among breast, colorectal, or endometrial cancer patients: A nationwide data linkage study.
    Feng JL; Qin X
    Diabetes Res Clin Pract; 2021 May; 175():108755. PubMed ID: 33836207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin use reduced the risk of stomach cancer in diabetic patients in Korea: an analysis of Korean NHIS-HEALS database.
    Kim J; Hyun HJ; Choi EA; Kim Y; Bae YJ; Kang HT
    Gastric Cancer; 2020 Nov; 23(6):1075-1083. PubMed ID: 32462322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis.
    Campbell JM; Bellman SM; Stephenson MD; Lisy K
    Ageing Res Rev; 2017 Nov; 40():31-44. PubMed ID: 28802803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.